All Episodes
Displaying 91 - 120 of 122 in total
New Hope For Glaucoma... Dr. Chris Nave, Managing Director of Brandon Capital and Chair of PolyActiva
Join us as Dr. Chris Nave, the managing director of Brandon Capital and Chair of PolyActiva, reveals groundbreaking advancements in eye treatments on this week's episo...
The Beauty Contest... Winner Goes to Phase I - Dr. Richard Austin, Founder & CEO Reglagene
Join Dr. Richard Austin, Founder and CEO of Reglagene, as he reveals the intense process of selecting the most promising drug candidate for treating brain cancer. Delv...
Sticky Proteins??? Alzheimer's, Parkinson's, and ALS...Dr. Maria Maccecchini, President & CEO, Annovis Bio
This week we explore the commonalities among neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS. Dr. Maria Macccecchini, Founder and CEO of Annovis ...
When Your Distant Cousins ID You For Murder… Ed Humes, Author of "The Forever Witness"
Moira speaks with Pulitzer Prize-winning author, Ed Humes. His latest is “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double Murder.” We get an obje...
Are Fibroblasts All Over My Body??? Dr. Hamid Khoja, CSO at FibroBiologics
Dr. Hamid Khoja, Chief Scientific Officer of Fibro Biologics, discusses the potential of fibroblasts in regenerative medicine, highlighting their abundance and diverse...
Engineering Viruses to Treat Solid Tumors... Dr. Paul Peter Tak, CEO of Candel Therapeutics
Dr. Paul Peter Tack, CEO of Candel Therapeutics, unveils their groundbreaking approach to cancer treatments using engineered viruses. Discover how these viruses are ha...
AI Three Different Ways to a New Drug??? Dr. Francois Vigneault, Co-Founder & CEO Shape Therapeutics
Discover the limitless potential of mRNA engineering as Dr. Francois Vigneault, Co-Founder and CEO of Shape Therapeutics, discusses their groundbreaking work in using ...
Fighting the Most Advanced Prostate Cancer... Dr. Philip Kantoff, CEO Convergent Therapeutics
200,000 men at diagnosed each year with Prostate cancer … beginning a journey of many successive treatments. Still, 35,000 men die as a result of prostate cancer. Conv...
A Different Approach, A New Cancer Drug... Dr. Paul Lammers, CEO Triumvira Immunologics
Cancer treatments which work with the immune system are making great strides, with Keytruda from Merck being perhaps the best known. Still there is much work to be don...
Are Your Genes Failing You??? Dr. Noah Davidsohn, Co-Founder & CSO Rejuvenate Bio
Dr. Nolan Davidson, the Co-Founder and Chief Scientific Officer of Rejuvenate Bio, discusses the importance of regulating protein expression and the role it plays in a...
25 Years in the Making - Treatment in Schleroderma? Dr. Darren Kelly, CEO, Certa Therapeutics
Dr. Darren Kelly, a professor and researcher at the University of Melbourne and the Founder and CEO of Certa Therapeutics, tells us about their clinical trials address...
Fatty Liver, NASH, Cirrhosis - Can They Be Stopped??? Dr. Robert Foster, CEO Hepion Pharmaceuticals
Did you know that 1 in 4 Americans suffer from fatty liver disease? And that can lead to a more serious condition called Nash, which can ultimately cause cirrhosis of ...
Hand Foot Skin Reaction - A Painful Chemotherapy Side Effect - Could There Be a Treatment?? Dr. Mike McCullar, CEO of OnQuality Pharmaceuticals
A side effect of chemotherapy, where hands and feet may be raw, painful, and immobilized. With no current treatment, a new candidate has just finished Phase II clinica...
Has Medtech Excluded Persons of Color & Women?? Dr. Patrice Matchaba President, Novartis US Foundation
Dr. Patrice Matchaba, the President of the Novartis US Foundation, shows us how medical technology can create systemic racism, both in the medical field and in human c...
Safe NON-OPIOID Pain Relief - Is It Possible? Dr. Hernan Bazan, Co-Fdr & CEO, South Rampart Pharma
The next generation of pain relief – non-opioid pain relief - with the goal of being equally powerful pain relief without addiction. Dr Hernan Bazan is the Co-Founder ...
Long Covid related to Fibromyalgia? Dr. Seth Lederman, Tonix Pharmaceuticals
Dr. Seth Lederman, Co-Founder and CEO of Tonix Pharmaceuticals, tells us that Long Covid may be related to Fibromyalgia. Now recruiting in advanced Human Clinical Tria...
The Oxford Dodo? ... Joe Hernandez, Blue Water Vaccines
Even Saturday Night Live couldn’t resist the story of a “genetics engineering company” trying to de-extinct the dodo bird. Blue Water Vaccines, founder and CEO Joe Her...
Getting Immune Systems to Recognize HER2+ tumors - Dr. Randy Schatzman, President & CEO, Bolt Biotherapeutics
Bolt Biotherapeutics’ Dr. Randy Schatzman talks about the role of myeloid cells in teaching our immune systems to recognize tumors in our own bodies and then eliminate...
22-45 Getting a Vaccination? What about a nasal spray?
Dr. Robert Coleman, the Co-Founder and CEO of Codagenix, shows us how to precisely engineer viruses to be effective vaccines, which can be delivered nasally – you hear...
23-03 Dr. Rob Ross, CEO, Surface Oncology
Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
23-01 Gene Kinney, President & CEO, Prothena Biosciences
Prothena's 1-2-3 punch for Alzheimer’s + their work in Parkinson’s, ALS, and the role of Amyloids in Down Syndrome
22-52 Edward Humes, Pulitzer Prize Winner, "The Forever Witness"
In a long-form feature from Tech Nation, it’s Pulitzer Prize-winning author, Edward Humes, with “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double ...
22-51 Keven Ali, CEO, Organon
A new global company with 64 products, many of which are for women? Kevin Ali is the CEO of Organon.
22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR Therapeutics
Cancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO,...
22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTx
Like the idea of replacing some of your DNA with DNA that works better? And what if you want that new DNA to stop? Dr. Alexandria Forbes, the President & CEO of MeiraG...
22-48 Dr. Robert Ang, President & CEO, Vor Biopharma
Vor Biopharma has a unique approach to a particular kind of cancer – Acute Myeloid Leukemia – perhaps better known to you, as AML. Dr. Robert Ang is Vor's President & ...
22-47 Dr. James Mackay, President & CEO, Aristea Therapeutics
Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's c...
22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis Bio
Alzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they...
22-16 Triple-Negative Breast Cancer is the most aggressive of all
Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has...
Dr. George Yancopoulos, CEO, Regeneron
Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid tre...